ZBP1 and schizophrenia: Rather, we suggest that the analysis of miR-99b-5p levels in blood may eventually help stratify patients for treatment, including novel approaches based on RNA therapeutics towards miR-99b-5p or Zbp1. Finally, it will be important to study whether miR-99b-5p plays a role in other neuropsychiatric diseases or if it is specifically deregulated in schizophrenia patients.